Koers Clearmind Medicine Inc. Canadian Securities Exchange
Aandelen
CMND
CA1850534027
Biotechnologie & Medisch Onderzoek
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 1,78 mln. 2,44 mln. 1,67 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -9 mln. -12,29 mln. -8,41 mln. | Nettowinst (verlies) 2023 | -8 mln. -10,93 mln. -7,47 mln. | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 388K 530K 362K | Nettoliquiditeiten 2023 | 5,51 mln. 7,53 mln. 5,15 mln. | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-1,09
x | K/w-verhouding 2023 |
-0,09
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 100% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+2,03% | 42,59 mld. | |
+8,13% | 40,65 mld. | |
+49,22% | 40,57 mld. | |
-12,36% | 26,77 mld. | |
+8,76% | 24,81 mld. | |
-24,46% | 18,17 mld. | |
+29,03% | 12,05 mld. | |
-2,66% | 11,7 mld. | |
+6,88% | 11,1 mld. |